{{Rsnum
|rsid=2039461
|Chromosome=9
|position=20145990
|Orientation=plus
|GMAF=0.3251
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 11.5 | 44.2 | 44.2
| HCB | 82.5 | 15.3 | 2.2
| JPT | 77.0 | 21.2 | 1.8
| YRI | 87.8 | 12.2 | 0.0
| ASW | 54.4 | 43.9 | 1.8
| CHB | 82.5 | 15.3 | 2.2
| CHD | 83.5 | 16.5 | 0.0
| GIH | 24.8 | 47.5 | 27.7
| LWK | 91.8 | 8.2 | 0.0
| MEX | 50.0 | 43.1 | 6.9
| MKK | 80.1 | 17.9 | 1.9
| TSI | 9.9 | 50.5 | 39.6
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs2039461
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19118814
|Annotation=This variant is significantly associated with late-onset Alzheimer disease (LOAD) in a GWAS study with 492 LOAD cases and 498 cognitive controls using Illumina's HumanHap550 beadchip.
|Drugs=
|Drug Classes=
|Diseases=Alzheimer Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA162363823
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2039461
|overall_frequency_n=42
|overall_frequency_d=118
|overall_frequency=0.355932
|n_genomes=22
|n_genomes_annotated=0
|n_haplomes=29
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | NatGeo2}}